
Micropime T 1000mg/125mg Injection
Marketer
Micro Labs Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Micropime T 1000mg/125mg Injection
Combitix-T, a dual-antibiotic injection (1000mg/125mg), combats bacterial infections by inhibiting microbial growth. Administration must be overseen by a qualified medical practitioner. Complete the prescribed treatment regimen, regardless of symptom improvement. Missed doses should be avoided. Common side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) are typically temporary. Severe or persistent side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., hives, itching, swelling, breathing difficulties). Inform your doctor of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Uses of Micropime T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Micropime T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Micropime T 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Micropime T 1000mg/125mg Injection:
Administering this medication will be performed by your doctor or nurse; self-medication is strictly prohibited.
How Micropime T 1000mg/125mg Injection works:
Micropime T Injection (1000 mg/125 mg) combines the antibiotic cefepime with the beta-lactamase inhibitor tazobactam. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thus broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Micropime T 1000 mg/125 mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Micropime T 1000 mg/125 mg Injection is typically deemed safe for use during gestation. Preclinical trials in animals have indicated minimal or absent harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Micropime T 1000 mg/125 mg Injection is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Micropime T 1000 mg/125 mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
For individuals with impaired kidney function, administration of Micropime T 1000 mg/125 mg Injection requires careful monitoring. Dosage modification of Micropime T 1000 mg/125 mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Micropime T 1000 mg/125 mg Injection in patients with liver impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Micropime T 1000mg/125mg Injection :
Omit a dose of Micropime T 1000 mg/125 mg Injection? Seek your physician's advice.
Facts to Know About Micropime T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-Infective Agents |
